Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

Linden, Hannah M

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313). [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2007 - 656-61 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

1527-7755

10.1200/JCO.2006.07.0847 doi


Adult
Age Factors
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Middle Aged
Neoplasm Invasiveness--pathology
Neoplasm Staging
Probability
Risk Assessment
Statistics, Nonparametric
Survival Analysis
Time Factors